Meetings/Workshops on Immunology and allergic diseases in the United States (USA)

Submit a meeting

Select a location:
Austria (1) - Canada (3) - Germany (1) - India (1) - Iran (1) - Israel (1) - Italy (2) - Russia (1) - Spain (1) - Sri Lanka (1) - United States (7) - ALL COUNTRIES (20)

1
Gordon Research Conference — Food Allergy
07 Jan 2018 - 12 Jan 2018 • Ventura, CA, United States
Topics:
Mechanisms, Prevention of, and Emerging Therapies for Food Allergy
Event listing ID:
960262
Related subject(s):
2
Keystone Symposia: Translational Systems Immunology
28 Jan 2018 - 01 Feb 2018 • Snowbird, Utah, United States
Abstract:
This conference will cover the exciting technology advances that are enhancing our ability to elucidate human immune function and networks as well as practical applications in drug and biomarker discovery and patient stratification. The meeting begins with a look at progress in human genetics and the use of sequencing to assign functional mutations to rare human immune phenotypes. The impact of common variants on immune function requires larger sample sizes, and speakers will cover how genome-wide high-throughput genomics in combination with detailed phenotyping and physiologically relevant perturbations are providing foundational data sets that allow an unbiased view of immune function in cells and tissues. Also discussed will be emerging computational and analytical methods that enable integration and interpretation of high-content molecular data. The meeting will then move on to look at the application of these technological advances, expanding investigation to study the immune response in tissues and organs to enable a deeper understanding of interaction between immune and non-immune cells and their respective roles in disease states. Critical to clinical progress is the translation of systems immunology research into novel therapies and diagnostic or prognostic tests. Sessions themed around infectious disease and vaccine development advances in immune-oncology and patient stratification in complex disease and treatment response aim to provide depth from foundational science to clinical translation. Finally, a key goal is fostering collaboration across disciplines and the development of novel ideas. The meeting will be relevant for immunologists, computational biologists and clinicians with an interest in molecular characterization of the immune system.
Contact:
Attendee Services;     Phone: [970.262.1230 or 800.253.0685];     Email: info@keystonesymposia.org
Topics:
immune-oncology, genomics, physiology, vaccine development, infectious diseases, translational medicine
Event listing ID:
926124
Related subject(s):
3
Keystone Symposia - Phosphoinositide Biology: New Therapeutic Targets Beyond Class I PI3K
11 Feb 2018 - 15 Feb 2018 • Taos, New Mexico, United States
Abstract:
Phosphoinositides have been recognized since the 1980s as important regulatory lipids supporting signal transduction from G protein-coupled receptors and receptor tyrosine kinases. The discovery of PI 3-kinases and their roles in carcinogenesis and immune regulation has created a fertile ground for translational expansion of the phosphoinositide field with a focus on cancer and inflammation. Most of these advances focused on Class I PI3Ks and PIP3-mediated signaling. However, research on other PI kinases and phosphoinositides has expanded substantially over the years. Class II and -III PI 3-kinases and less characterized 3-phosphorylated phosphoinositides are now rapidly emerging as key controllers of development, trafficking, nutrition-sensing and autophagy. Furthermore, phosphoinositides different from the 3-phosphorylated species are gaining momentum in many aspects of cell physiology and pathology. Exciting new developments include PI 4-kinases controlling vesicular trafficking and non-vesicular lipid transfer between membrane contacts, and new details are emerging on the role of inositol lipid phosphatases in trafficking, endocytosis and ciliary function. The recently recognized roles of PI 4-kinases as obligate host factors for certain RNA viruses, and their importance in parasitic organisms such as Plasmodium falciparum or Legionella pneumophila, have raised significant interest from pharmaceutical companies that now focus on inositol lipids other than the products of PI 3-kinases. By expanding our knowledge of phosphoinositides beyond class I PI3K products, this Keystone Symposia meeting represents a unique opportunity to bolster the rising interest in these under-explored avenues with a strong potential for translational impact.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
development, drug discovery, cancer, infectious disease, cell signaling, genetics, cell physiology
Event listing ID:
948508
4
Keystone Symposia - Emerging Cellular Therapies: T Cells and Beyond
11 Feb 2018 - 15 Feb 2018 • Keystone, Colorado, United States
Abstract:
A new community of researchers is emerging that focuses on studying and developing cellular therapies against cancer and chronic infections. The field is advancing rapidly due to our deepening understanding of cell biology. New technologies permit efficient cell culture, gene transfer and genetic editing, enabling autologous and allogeneic cell therapy. With rapid development of CAR T cells, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce in the biotechnology and pharmaceutical industries. Cell therapies with stem cells and T cells are in advanced clinical development that will enable widespread use for cancer and chronic infections such as HIV. Infusions of regulatory T cells (Tregs) have the potential to benefit patients with autoimmunity and transplantation. A goal of this conference is to bring together basic and translational scientists from these fields to identify current opportunities and challenges in cell therapies. Another goal is to bridge the fields of effector T cell and Treg cell therapies. The interdisciplinary features of this meeting should facilitate new collaborations and interactions between investigators who would not normally meet. This meeting is paired with the Keystone Symposia conference on "Lymphocytes and their Roles in Cancer."
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
T cell and B cell biology, cancer, genetics, genomics, drug discovery, infectious disease, HIV, translational medicine, stem cells
Event listing ID:
948518
Related subject(s):
5
Keystone Symposia: Lymphocytes and their Roles in Cancer
11 Feb 2018 - 15 Feb 2018 • Keystone, Colorado, United States
Abstract:
Leverage of the body’s own immune system is revolutionizing the way that we treat cancer as it can lead to dramatic and durable responses. Such anti-tumor therapies include reactivation of anti-tumor T cells, expansion of tumor-infiltrating lymphocytes (TILs), Chimeric antigen receptor (CAR) T cells and a variety of cancer vaccines. The focus or target of most these approaches are cells of the lymphocytic lineage (T, B, NK, dendritic cells), key components of both adaptive and innate immune response. At the same time, lymphocytes can also be malignant, as in the case of a large number of lymphocytic leukemia and lymphoma subtypes, and active components of the immune microenvironment, controlling tumor growth and anti-tumor response. This conference for the first time brings together scientists from these different areas of lymphocyte biology and provides an overview of lymphocyte development, transformation, terminal differentiation, location within the tumor microenvironment and anti-tumor activity. The conference also provides an update on novel therapy protocols that attempt to harness the function of lymphocytes against cancer and state-of-the-art technologies, including imaging and DNA/RNA sequencing approaches, that will help us visualize and molecularly dissect anti-tumor responses in experimental systems and cancer patients.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
cancer, immunology, drug discovery, technologies, T cell biology, genetics, genomics
Event listing ID:
948526
Related subject(s):
6
Gordon Research Seminar — Immunochemistry and Immunobiology
09 Jun 2018 - 10 Jun 2018 • Mount Snow, West Dover, VT, United States
Topics:
Engineering the Immune System: Applications in Clinical and Technological Translation
Event listing ID:
960510
7
Gordon Research Conference — Immunochemistry and Immunobiology
10 Jun 2018 - 15 Jun 2018 • Mount Snow, West Dover, VT, United States
Topics:
Advances in Immunology and Immunotechnology: Insights in the Regulation of Protective and Pathological Immune Responses
Event listing ID:
960588

View all listed conferences in the United States (USA).



Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Last updated: 22 October 2017